Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
about
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cellsThe lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cellsLysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiationLysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.Gene expression pathways of high grade localized prostate cancer.Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenograftsBlimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide.High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells.GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling.High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.Lysyl oxidase, extracellular matrix remodeling and cancer metastasisLysyl oxidase mediates hypoxia-induced radioresistance in non-small cell lung cancer A549 cellsLysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.Inflammasomes in carcinogenesis and anticancer immune responses.Lysyl oxidase in colorectal cancer.Human copper-dependent amine oxidases.EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.Sex-Linked Skeletal Phenotype of Lysyl Oxidase Like-1 Mutant Mice.Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptideLysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma.Characterization of recombinant lysyl oxidase propeptide.Functional importance of lysyl oxidase family propeptide regions.Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling.Lysyl oxidase family members in urological tumorigenesis and fibrosis.Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
P2860
Q24301022-F73739B4-0B9B-43E3-A50E-8ED1690F631EQ24307235-07FE4C71-3184-470A-9E36-B77162F89028Q28587970-743D23CF-67B2-430F-BF8A-A3FEEA614A77Q33748104-74317ED0-27BA-459B-8246-5D72BC25F219Q33832517-FC6C85E9-3062-48DE-8D06-E1FA03CC3ED4Q33867402-A089254A-8A3E-4174-96FA-1A28E605832CQ34170606-D03C4268-1890-4648-9A38-8439A4E8EFBDQ34206164-55CC0E34-DA19-4F64-A027-45CFF59AAE75Q34355294-D6888234-86E6-434B-9C15-DA528A859DACQ34764399-198E06D6-898E-4F72-BCEC-15813D61410DQ35605895-C859EFB7-F50A-4C9F-ABA7-F335BF598485Q35688339-898B43E6-88F3-41E8-B2A7-483DB7EF04D8Q35821224-550EEA6E-25F0-4ABD-8879-D20EEF1CBE3DQ36284915-C8428A80-8FF9-43EA-9976-867D6F101CAEQ37071613-2489A30D-53F5-4DFC-ACD7-8252CFA0A960Q37532942-327C3771-1065-48B5-ABF9-B2FA7D7BBD33Q37995072-C9574587-D7AB-4AA9-8145-4A307B6A0CEDQ38134562-65280281-1347-421C-9DB0-F76F3411D21EQ38177145-B779605E-456F-471C-8AB7-2F8C688139D1Q38563638-476B6252-2666-4726-B767-18953A46D380Q38723997-52F7F7B7-07B0-4EE9-ACF5-5098AC8B7C3BQ38841862-F3682C04-0DAA-4EFF-B03A-CF39CF32985EQ38989588-3996F08E-22A2-42E7-8C50-0D32EA5D1B72Q39376172-9EE9A6C6-FF41-47FC-86E0-ADBC34E81EC1Q40068242-6903F794-D70E-42C4-8574-4080E894C648Q40251892-BD9FB847-C070-4CD0-B8B7-75CD649045F0Q40354992-D59774B4-F848-45F3-A891-BFCFE47B8FB2Q41694382-6F8EF5BB-2DBA-44F6-96DD-A10457516981Q41898229-3DBE6E00-36B8-4A74-A07F-709D119DB0F4Q42720975-A558B80F-F713-418A-BDC3-EDEA5AF2EE7EQ42853848-32323E1E-60F4-440E-B372-CA1DA961918FQ47584936-4C7CDDA1-967E-45A0-8BA6-A5F7226AB52FQ49277335-8A424978-95B3-4BAF-840B-73DFB96BBC6AQ55176262-EB2CEDA0-30D8-4922-86BA-A9A37DF875DCQ55516291-44D00EC7-15D5-4114-9CCE-B0E710E70CB9
P2860
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@en
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@nl
type
label
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@en
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@nl
prefLabel
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@en
Lysyl oxidase propeptide inhib ...... -2-cell binding and signaling.
@nl
P2093
P2860
P356
P1433
P1476
Lysyl oxidase propeptide inhib ...... F-2-cell binding and signaling
@en
P2093
A H Palamakumbura
G E Sonenshein
M A Nugent
P2860
P2888
P304
P356
10.1038/ONC.2009.203
P407
P577
2009-07-13T00:00:00Z